BCL2 and cancer: The frequency of mutations in the miRNA biogenesis genes is similar to that in cancer-specific drivers, such as MYC, ALK, CACNA1A, POLE, BCL2, NOTCH2, MET, HRAS, FGFR and PIK3R1, with pan-cancer mutation frequencies up to ∼3% (122).